US 10160736
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
granted A61KA61K31/4245A61K31/433
Quick answer
US patent 10160736 (1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4245, A61K31/433, A61K45/06, A61P